Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
Enveric Biosciences, a biotech firm focused on developing treatments for psychiatric and neurological conditions, is set to participate in the B. Riley Securities Mind, Muscle & Vision Summit in Boston. CEO Joseph Tucker will represent the company, highlighting its advancements in neuroplastogenic small-molecule therapeutics. This event participation underscores Enveric's growing presence in the biotech sector and its commitment to innovative research in mental health treatments, potentially attracting investors and collaborators interested in its promising pipeline.
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.